Patients with HIV or AIDS deserve affordable treatment — but one man has really thrown a wrench in that plan by trying to take away a drug that can help immunocompromised patients.
Martin Shkreli, CEO of Turing Pharmaceuticals, recently raised the price of Daraprim, a drug used to treat rare parasitic infections